Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Acadia Healthcare Company Inc (ACHC) vs Booz Allen Hamilton Holding Corporation (BAH) Price & Performance

Acadia Healthcare Company Inc
Booz Allen Hamilton Holding Corporation

Price performance

Price movement over the last 24 hours

Key statistics

Acadia Healthcare Company Inc vs Booz Allen Hamilton Holding Corporation — how do they compare? Acadia Healthcare Company Inc trades at $30.67 (market cap $2.94B), while Booz Allen Hamilton Holding Corporation trades at $62.87 (market cap $7.59B). The key difference: Booz Allen Hamilton Holding Corporation is far larger — about 2.6× Acadia Healthcare Company Inc's market cap, and Booz Allen Hamilton Holding Corporation pays a 3.73% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.

ACHCBAH
Market Cap
$2.94B$7.59B
Sector
HealthIndustrials
52-Week High
$31.92$115.95
52-Week Low
$11.68$59.71
Enterprise Value
$5.45B$10.99B
Dividend Yield
3.73%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Acadia Healthcare Company Inc

ACHC trades at $31.09, down 2.57% today but maintains a bullish technical outlook with strong moving average support. The company shows operational strength with three consecutive earnings beats, though profitability remains challenged with a -32.84% net margin. Analyst consensus is strongly bullish with 68% buy ratings, while recent news highlights the company's strategic shift toward profitability and rising behavioral health demand.

The stock presents a mixed opportunity with strong technical momentum and analyst support offset by persistent profitability challenges. Key catalysts include continued earnings outperformance and successful execution of the turnaround strategy, while risks center on margin pressures and high short interest that could limit upside potential.

Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton (BAH) trades at $63.31, up 1.38% with mixed technical signals showing bearish moving averages but neutral oscillators. The company demonstrates strong fundamentals with revenue growth to $12.0B in 2025 and impressive profitability metrics including 80.17% ROE. Recent developments include strategic AI partnerships with OpenAI and acquisitions to strengthen defense technology capabilities, though the stock faces near-term pressure from civil business weakness.

BAH presents a compelling value opportunity with attractive valuation multiples (P/E 9.03, P/S 0.68) and analyst consensus target of $87.25 representing 38% upside. However, investors face risks from FY27 transition expectations, civil segment pressures, and technical resistance near $64-65 levels. The company's government-focused model provides stability amid market volatility.

Returns comparison

Trailing returns across standard periods

About Acadia Healthcare Company Inc

Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.

Read more on ACHC

About Booz Allen Hamilton Holding Corporation

Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.

Read more on BAH